医学部・心臓血管外科学

Keyphrases

1. Abdominal Aortic Aneurysm Repair 30%
2. Above-knee Amputation 7%
3. Acute Deep Venous Thrombosis 15%
4. Albumin 15%
5. Angiogenesis Factor 30%
6. Angiogenic Potential 9%
7. Ankle Blood Pressure 30%
8. Antibiotic Agents 7%
9. Aortic Stump 30%
10. Aortoiliac Occlusive Disease 30%
11. Area under the Curve 15%
12. Arterial Surgery 30%
13. Ascending Aorta Replacement 30%
14. Behçet's Disease 12%
15. Blood Loss 7%
16. Body Extension 9%
17. Circulating EPCs 9%
18. Claudicant 8%
19. Claudication 30%
20. Coldness 7%
21. Condemn 7%
22. Critical Ischemia 30%
23. Cusp 22%
24. Cutaneous Fistula 15%
25. Deep Vein Thrombosis 15%
26. Dispersion Wave 30%
27. Endarteritis Obliterans 30%
28. Endothelial Cell Activation 30%
29. Endovascular Retrieval 15%
30. Fabric Tears 30%
31. Femoropopliteal Bypass 30%
32. Gradual Growth 9%
33. Hemoglobin 7%
34. Hydrophilic Statin 30%
35. In-hospital Mortality 22%
36. Independent Risk Factors 7%
37. Inferior Vena Cava Filter 30%
38. Inferior Vena Cava Filter Retrieval 30%
39. Inflammatory Aneurysm 17%
40. Influenza B 30%
41. Internal Elastic Lamina 7%
42. Intestinal Involvement 30%
43. Intestinal Ischemia 9%
44. Ischemic Limb 30%
45. Japan 30%
46. Jet Stream 7%
47. Left Ventricular Aneurysmectomy 30%
48. Leg Swelling 7%
49. Lower Extremity Arterial Disease 30%
50. Lower Extremity Veins 30%
51. Major Axis 20%
52. Massive Pulmonary Embolism 7%
53. Membranous Septal Aneurysm 30%
54. Minor Axis 30%
55. Morbidity Rate 7%
56. Morbidity Risk 30%
57. Mortality Risk 30%
58. Multivariate Analysis 15%
59. Mycotic Abdominal Aortic Aneurysm 24%
60. Open Repair 30%
61. Operative 30%
62. Operative Time 7%
63. Organized Thrombus 9%
64. Oscillometric Device 30%
65. Oscillometry 12%
66. Pericardial Abscess 30%
67. Peripheral Arterial Occlusion 7%
68. Persistent Left Superior Vena Cava (PLSVC) 30%
69. Polyurethane Graft 30%
70. Popliteal Artery Aneurysm 30%
71. Popliteal Venous Aneurysm 30%
72. Postoperative Venous Thromboembolism 7%
73. Prognostic Factors 7%
74. Rare Vascular Disease 7%
75. Receiver Operating Characteristic Analysis 15%
76. Renal Disease 15%
77. Repair Approach 7%
78. Retrospective Cohort Study 7%
79. Risk Profile 7%
80. Risk Scoring System 7%
81. Ruptured Abdominal Aortic Aneurysm (rAAA) 7%
82. Severity Score 30%
83. Stump Closure 30%
84. Subclavian Artery Aneurysm 30%
85. Teflon Felt 15%
86. Therapeutic Angiogenesis 15%
87. Thrombosis Event 7%
88. Tingling 7%
89. Type III Endoleak 30%
90. Univariate Analysis 15%
91. Urokinase-type Plasminogen Activator 18%
92. Vasa Vasorum 30%
93. Vasculo-behçet's Disease 30%
94. Vein Graft 30%
95. Venous Aneurysm 9%
96. Venous Thromboembolism Prophylaxis 30%
97. Venous Thrombus 9%
98. VSD Closure 7%
99. Western Countries 7%
100. Zenith Stent Graft 30%

Medicine and Dentistry

1. 4 [3 (1h Tetrazol 5 Yl) 8 Coumarinyloxy]butyric Acid 5%
2. Abdominal Aortic Aneurysm 100%
3. Abdominal Aortic Aneurysm Repair 30%
4. Amikacin 30%
5. Analysis of Variance 6%
6. Aneurysm 80%
7. Aneurysm Surgery 5%
8. Angiogenic Factor 30%
9. Aortic Reconstruction 8%
10. Aortic Wall 6%
11. Aortoenteric Fistula 15%
12. Arteriosclerosis Obliterans 30%
13. Artery 7%
14. Artery Surgery 30%
15. Behcet Disease 30%
16. Below Knee Amputation 7%
17. Bleeding 9%
18. Bowel Ischemia 9%
19. Cardiopulmonary Resuscitation 15%
20. Cell Nucleus Antigen 6%
21. Cell Proliferation 9%
22. Clinical Feature 30%
23. Clinical Significance 5%
24. College Student 7%
25. Computer Assisted Tomography 35%
26. Coronary Angiography 11%
27. Coronary Artery Bypass Graft 30%
28. Deep Vein Thrombosis 9%
29. Disease 27%
30. Echography 5%
31. Endoleak 30%
32. Endovascular Aneurysm Repair 30%
33. Femoropopliteal Bypass 30%
34. Fibrin Glue 30%
35. Fractional Flow Reserve 30%
36. Haemophilus influenzae 15%
37. Haemophilus Influenzae Type B 30%
38. Health Care Cost 30%
39. Heart Muscle Ischemia 7%
40. Histopathology 6%
41. Hospital Mortality 30%
42. Image Reconstruction 15%
43. Infective Endocarditis 30%
44. Inferior Vena Cava Filter 30%
45. Intimal Hyperplasia 30%
46. Microvessel 6%
47. Midkine 13%
48. Morbidity 9%
49. Mortality Rate 9%
50. Mosaicism 7%
51. Multivariate Analysis 20%
52. Nephropathy 20%
53. Obliterating Endarteritis 60%
54. Operation Duration 9%
55. Outpatient 6%
56. Percutaneous Coronary Intervention 7%
57. Peripheral Aneurysm 6%
58. Pitavastatin 30%
59. Plasminogen Activator Inhibitor-1 30%
60. Polyurethan 30%
61. Popliteal Artery Aneurysm 30%
62. Pravastatin 30%
63. Prognostic Factor 9%
64. Prophylaxis 5%
65. Protein Jagged 1 12%
66. QT Dispersion 18%
67. Recombinant Granulocyte Colony Stimulating Factor 5%
68. Retrospective Cohort Study 9%
69. Scoring System 9%
70. Skin Fistula 15%
71. Stenosis 7%
72. Stent-Graft 30%
73. Stromelysin 18%
74. Subcutaneous Tissue 30%
75. Surgery 8%
76. Thromboembolism 5%
77. Thrombosis 5%
78. Tricuspid Valve Replacement 7%
79. Univariate Analysis 20%
80. Urokinase 18%
81. Vasa Vasorum 30%
82. Vascular Disease 36%
83. Vascular Endothelial Cadherin 5%
84. Vasculotropin 13%
85. Vein Aneurysm 60%
86. Vein Graft 60%